HDAC4/HDAC5/HDAC9 (pSer246), (pSer259), (pSer220) antibody

Details for Product No. ABIN319280
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

pSer246, pSer259, pSer220
(4), (4), (4), (2), (2), (2)
Human, Mouse (Murine)
(6), (4)
Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
(6), (3), (3), (2), (2)
Pubmed 4 references available
Catalog no. ABIN319280
Quantity 50 µg
286.00 $   Plus shipping costs $45.00
Shipping to United States (Change)
Availability Will be delivered in 6 to 8 Business Days

Order hotline:

  • +1 404 474 4654
  • +1 888 205 9894 (TF)
Immunogen The antiserum was produced against synthesized phosphopeptide derived from human HDAC4/HDAC5/HDAC9 around the phosphorylation site of Serine 246/259/220 (T-A-SP-EP).
Specificity HDAC4/HDAC5/HDAC9 (Phospho-Ser246/259/220) Antibody detects endogenous levels of HDAC4/HDAC5/HDAC9 only when phosphorylated at Serine 246/259/220.
Purification Immunoaffinity Chromatography: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific phosphopeptide. The antibody against non-phosphopeptide was removed by chromatography using non-phosphopeptide corresponding to the phosphorylation site.
Background Alternate names: HDAC-4, HDAC-5, HDAC-9, Histone Deacetylase
Application Notes Western Blot (1/500-1/1000). Immunohistochemistry (1/50-1/100). Other applications not tested. Optimal dilutions are dependent on conditions and should be determined by the user.
Restrictions For Research Use only
Format Liquid
Buffer PBS (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02% Sodium Azide and 50% Glycerol.
Preservative Sodium azide
Handling Advice Avoid repeated freezing and thawing.
Storage -20 °C
Storage Comment Store the antibody (in aliquots) at-20°C.
Expiry Date 12 months
Supplier Images
anti-HDAC4/HDAC5/HDAC9 (pSer246), (pSer259), (pSer220) antibody anti-HDAC4/HDAC5/HDAC9 (pSer246), (pSer259), (pSer220) antibody
anti-HDAC4/HDAC5/HDAC9 (pSer246), (pSer259), (pSer220) antibody (2) anti-HDAC4/HDAC5/HDAC9 (pSer246), (pSer259), (pSer220) antibody (Image 2)
Background publications Cress, Seto: "Histone deacetylases, transcriptional control, and cancer." in: Journal of cellular physiology, Vol. 184, Issue 1, pp. 1-16, 2000 (PubMed).

Marmorstein: "Structure and function of histone acetyltransferases." in: Cellular and molecular life sciences : CMLS, Vol. 58, Issue 5-6, pp. 693-703, 2001 (PubMed).

Thiagalingam, Cheng, Lee et al.: "Histone deacetylases: unique players in shaping the epigenetic histone code." in: Annals of the New York Academy of Sciences, Vol. 983, pp. 84-100, 2003 (PubMed).

Vigushin, Coombes: "Targeted histone deacetylase inhibition for cancer therapy." in: Current cancer drug targets, Vol. 4, Issue 2, pp. 205-18, 2004 (PubMed).

Hosts (6)
Reactivities (6), (4)
Applications (6), (3), (3), (2), (2)
Epitopes (4), (4), (4), (2), (2), (2)
back to top